Preview openPlanned full launch in
--Days--Hrs--Min--Sec
asceticpharma
← Peptide Intelligence

Copper-binding tripeptide

GHK-Cu

Copper tripeptide-1

A naturally occurring copper-binding tripeptide studied in skin biology, extracellular-matrix signalling and cosmetic formulations.

01

Licensed use — if any

Cosmetic ingredient research is not the same as approval of an injectable medicine. No injectable anti-ageing or recovery indication is established here.

02

Research interest

Skin remodelling, wound biology, hair and cosmetic formulation research, with evidence strength varying sharply by route and outcome.

Evidence lens

Known does not mean proven for everything.

The strongest claim on the page should never be stronger than the strongest source behind it.

What we can say
  • GHK-Cu has a larger laboratory and cosmetic literature than many online research peptides.
  • Topical-formulation evidence cannot establish the safety of injection.
  • FDA specifically flags injectable GHK-Cu because human safety data are limited.
What remains unknown
  • Long-term safety and meaningful clinical benefit of injectable products.
  • How well small cosmetic studies generalise to marketed claims.
  • Identity and contamination risk in non-regulated preparations.
Risk and caution
  • Injectable preparations may create immunogenicity and impurity concerns.
  • Copper exposure, formulation and route change the risk assessment.
  • Cosmetic wording should not be used to disguise a medicinal presentation.

Regulatory snapshot

Jurisdiction and context matter.

UK

Cosmetic and medicinal presentations follow different UK rules. Verify claims and route before marketing.

US

FDA's safety-risk page identifies limited human data for injectable GHK-Cu; no injectable therapeutic approval is presented.

Tested sport

Not treated here as sporting clearance. Athletes should check the current WADA list and the exact product through Global DRO.

Primary sources

Open the record.

Statuses change. Always check the current regulator, product label, trial record and anti-doping list.

  1. 01FDA · peptide compounding safety risks
  2. 02PubMed · GHK-Cu indexed research
  3. 03MHRA · medicines product database
This is not medical advice.

Do not start, stop or source a medicine based on this page. Speak to a qualified healthcare professional and use regulated supply routes. Call 999 in an emergency or NHS 111 for urgent advice.

Continue through the library →